These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

905 related articles for article (PubMed ID: 16323147)

  • 41. [Seroepidemiological studies of measles among girls and women in Poland].
    Imbs D; Lityńska J
    Przegl Epidemiol; 1982; 36(1-2):7-16. PubMed ID: 7146486
    [No Abstract]   [Full Text] [Related]  

  • 42. [Eradication of measles. Strategies in the Autonomous Community of Catalonia].
    Salleras Sanmartí L; Domínguez García A; Batalla Clavell J; Coll RP
    Rev Esp Salud Publica; 1999; 73(5):619-27. PubMed ID: 10650754
    [No Abstract]   [Full Text] [Related]  

  • 43. Sidestepping maternal antibody: a lesson from measles virus vaccination.
    Kim D; Niewiesk S
    Expert Rev Clin Immunol; 2011 Sep; 7(5):557-9. PubMed ID: 21895466
    [No Abstract]   [Full Text] [Related]  

  • 44. Decay of maternally derived measles antibody in central Turkey.
    Metintaş S; Akgün Y; Arslantaş D; Kalyoncu C; Uçar B
    Public Health; 2002 Jan; 116(1):50-4. PubMed ID: 11896637
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sero-epidemiological study of measles virus infection in and around Chandigarh.
    Broor S; Pal SR; Banerjee AK; Chitkara NL; Choudhury S
    Indian J Med Res; 1976 Dec; 64(12):1740-6. PubMed ID: 1024074
    [No Abstract]   [Full Text] [Related]  

  • 46. Passive acquired immunity against measles in infants born to naturally infected and vaccinated mothers.
    Szenborn L; Tischer A; Pejcz J; Rudkowski Z; Wójcik M
    Med Sci Monit; 2003 Dec; 9(12):CR541-6. PubMed ID: 14646978
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Age-dependence of measles immunization failures].
    Giesecke H; Brendel P; Schmidt J; Schlenk B
    Z Gesamte Hyg; 1980; 26(10):764-67. PubMed ID: 7467503
    [No Abstract]   [Full Text] [Related]  

  • 48. Measles and measles vaccination in isolated Amerindian tribes. II. The 1978/79 Xingu epidemic.
    Baruzzi RG; Abdala N; Black FL
    Trop Geogr Med; 1982 Mar; 34(1):7-12. PubMed ID: 7080192
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The resurgence of measles in the United States, 1989-1990.
    Atkinson WL; Orenstein WA; Krugman S
    Annu Rev Med; 1992; 43():451-63. PubMed ID: 1580601
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Seroconversion following vaccination with a new measles vaccine strain].
    Just M; Wegmann A
    Ther Umsch; 1983 Mar; 40(3):261-3. PubMed ID: 6857567
    [No Abstract]   [Full Text] [Related]  

  • 51. Measles susceptibility in two Pacific atoll populations. Epidemiological factors and response to live attenuated measles virus.
    Willis MF; Warburton MF
    Med J Aust; 1974 May; 1(20):789-93. PubMed ID: 4853112
    [No Abstract]   [Full Text] [Related]  

  • 52. Comparison of plaque reduction neutralisation test (PRNT) and measles virus-specific IgG ELISA for assessing immunogenicity of measles vaccination.
    Cohen BJ; Doblas D; Andrews N
    Vaccine; 2008 Nov; 26(50):6392-7. PubMed ID: 18834911
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Review of the effect of measles vaccination on the epidemiology of SSPE.
    Campbell H; Andrews N; Brown KE; Miller E
    Int J Epidemiol; 2007 Dec; 36(6):1334-48. PubMed ID: 18037676
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Measles IgA in the nasal washings of adult volunteers and children immunized intranasally with measles vaccine L-16.
    Liashenko VA; Krasnova VP; Youminova NV
    Hum Antibodies; 1999; 9(3):143-8. PubMed ID: 10690626
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Study of antibody titres after measles vaccination: fever within 7 days of vaccination and efficacy of booster doses.
    Egami T; Egami K; Tanoue A
    Arch Dis Child; 2008 Apr; 93(4):319-20. PubMed ID: 17488762
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effectiveness of measles inoculations in the Hungarian People's Republic].
    Erdös L
    Tr Inst Im Pastera; 1979; 53():19-25. PubMed ID: 262709
    [No Abstract]   [Full Text] [Related]  

  • 57. Sustained measles elimination in Australia and priorities for long term maintenance.
    Gidding HF; Wood J; MacIntyre CR; Kelly H; Lambert SB; Gilbert GL; McIntyre PB
    Vaccine; 2007 May; 25(18):3574-80. PubMed ID: 17300858
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Measles infection: an operational proposal for vaccine prophylaxis].
    Simonetti D'Arca A; Gatti Colangelo G; Mastroeni I
    Nuovi Ann Ig Microbiol; 1988; 39(4-5):431-8. PubMed ID: 3254495
    [No Abstract]   [Full Text] [Related]  

  • 59. Measles sero-immunity in rural non-vaccinated children of Busoga District, Uganda.
    Munube GM
    East Afr Med J; 1979 Jul; 56(7):335-8. PubMed ID: 520246
    [No Abstract]   [Full Text] [Related]  

  • 60. Measles seroepidemiology among adolescents and young adults: response to revaccination.
    Saffar MJ; Alraza-Amiri M; Ajami A; Baba-Mahmoodi F; Khalilian AR; Vahidshahi C; Shamsizadeh A
    East Mediterr Health J; 2006 Sep; 12(5):573-81. PubMed ID: 17333796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.